ArticleAnnals of surgical oncology2026
Improving Clear Cell Renal Cell Carcinoma Diagnosis: Modified CT Algorithms with Simplified Heterogeneity Scoring.
Article in Annals of surgical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTo refine a computed tomography (CT)-based algorithm for distinguishing clear cell renal cell carcinoma (ccRCC) from other small renal masses (SRMs ≤ 4 cm) through a simplified heterogeneity score and optimized attenuation criteria. PATIENTS AND
methodsThis multicenter retrospective study included 257 SRMs as an initial cohort and 149 for validation. A simplified heterogeneity score was developed incorporating persistent hypodense areas and tumor-parenchymal enhancement heterogeneity. Attenuation score was re-stratified using classification and regression tree analysis. Two modified systems were created: Modified Score 1 (original attenuation score + simplified heterogeneity score) and Modified Score 2 (new attenuation score + simplified heterogeneity score), compared against the original CT score.
resultsBoth modified scores outperformed the original system. Modified Score 1 achieved higher sensitivity (cutoff ≥ 4: 86.3% versus 69.1%, p < 0.001) and area under the receiver operating characteristic curve (AUC) (0.880 versus 0.793, p < 0.001); Modified Score 2 showed better specificity (85.6% versus 75.4%, p = 0.017) and AUC (0.907 versus 0.793, p < 0.001). The simplified heterogeneity score improved interobserver agreement (kappa: 0.736 versus 0.282) and drove improvements in the corresponding CT scores from 0.466 to 0.663 (score 1) and 0.577 (score 2) and from 0.459 to 0.833 and 0.712 in the five-tiered and dichotomous systems, respectively. The validation cohort confirmed the superior performance of the modified scores, including for SRMs ≤ 3 cm. Moreover, a simplified heterogeneity score of 3 demonstrated high specificity (90.6-94.0%) for diagnosing malignant SRMs.
conclusionsThe modified CT algorithms significantly improve diagnostic accuracy and reproducibility for ccRCC, supporting clinical decisions between active surveillance and intervention.
Indexed as
Identifiers
42183967What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.